The U.S. Senate committee has recently approved a bill that has the potential to restrict Chinese biotech companies from accessing American genetic data. This decision comes amidst growing concerns over national security and the protection of sensitive information.
The bill, which was passed by the Senate Committee on Foreign Relations, aims to address the perceived threat posed by Chinese biotech firms that may have ties to the Chinese government. Supporters of the bill argue that safeguarding genetic data is crucial to protecting national interests and preventing potential exploitation by foreign entities.
